DK123276B - Process for the preparation of an easily fluidizable inhalant. - Google Patents

Process for the preparation of an easily fluidizable inhalant.

Info

Publication number
DK123276B
DK123276B DK380968AA DK380968A DK123276B DK 123276 B DK123276 B DK 123276B DK 380968A A DK380968A A DK 380968AA DK 380968 A DK380968 A DK 380968A DK 123276 B DK123276 B DK 123276B
Authority
DK
Denmark
Prior art keywords
inhalant
preparation
easily fluidizable
fluidizable
fluidizable inhalant
Prior art date
Application number
DK380968AA
Other languages
Danish (da)
Inventor
S Gunning
P Hartley
Original Assignee
Fisons Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Pharmaceuticals Ltd filed Critical Fisons Pharmaceuticals Ltd
Publication of DK123276B publication Critical patent/DK123276B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
DK380968AA 1967-08-08 1968-08-07 Process for the preparation of an easily fluidizable inhalant. DK123276B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB36270/67A GB1242211A (en) 1967-08-08 1967-08-08 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
DK123276B true DK123276B (en) 1972-06-05

Family

ID=10386572

Family Applications (1)

Application Number Title Priority Date Filing Date
DK380968AA DK123276B (en) 1967-08-08 1968-08-07 Process for the preparation of an easily fluidizable inhalant.

Country Status (14)

Country Link
US (1) US3634582A (en)
JP (1) JPS5643448B1 (en)
BE (1) BE718846A (en)
CA (1) CA946280A (en)
DE (2) DE1792799A1 (en)
DK (1) DK123276B (en)
FI (1) FI48973C (en)
FR (2) FR8142M (en)
GB (1) GB1242211A (en)
IE (1) IE32343B1 (en)
MY (2) MY7400330A (en)
NL (1) NL161984C (en)
NO (1) NO128307B (en)
SE (1) SE372420B (en)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1381872A (en) * 1971-06-22 1975-01-29 Fisons Ltd Pharmaceutical compositions for inhalation
BE787100A (en) * 1971-08-06 1973-02-02 Beecham Group Ltd COMPOSITION FOR THE TREATMENT OF ASTHMA
GB1410588A (en) * 1971-08-10 1975-10-22 Fisons Ltd Composition
DE2332663C2 (en) * 1973-06-23 1986-07-31 Schering AG, 1000 Berlin und 4709 Bergkamen Use of corticosteroid active ingredients for inhalation therapy
DE2535258C2 (en) * 1974-08-10 1993-06-03 Fisons Plc, Ipswich, Suffolk Inhalable drug in pellet form
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
FI770215A (en) * 1976-01-30 1977-07-31 Fisons Ltd
GB2077100B (en) * 1980-04-30 1985-04-24 Fisons Ltd Pharmaceutical compositions containing cromoglycates
BE891013A (en) * 1980-11-05 1982-05-05 Fisons Ltd PHARMACEUTICAL COMPOSITIONS
JPS59163313A (en) * 1983-03-09 1984-09-14 Teijin Ltd Peptide hormone composition for nasal administration
US5204113A (en) * 1987-04-09 1993-04-20 Fisons Plc Pharmaceutical compositions containing pentamidine
JP2770970B2 (en) * 1987-04-09 1998-07-02 フアイソンズ・ピーエルシー Pharmaceutical composition containing pentamidine
DE4140689B4 (en) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalable powders and process for their preparation
ATE204750T1 (en) * 1992-06-12 2001-09-15 Teijin Ltd PHARMACEUTICAL PREPARATION FOR USE IN THE RESPIRATORY CIRCULATION
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US6794357B1 (en) 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
IS1736B (en) 1993-10-01 1999-12-30 Astra Ab Methods and devices that promote increased particle aggregation
EP0721331B1 (en) * 1993-10-01 2001-12-05 AstraZeneca AB Process i
NL9301851A (en) * 1993-10-26 1995-05-16 Cordis Europ Cryo-ablation catheter.
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
US6102036A (en) * 1994-04-12 2000-08-15 Smoke-Stop Breath activated inhaler
US6165976A (en) 1994-06-23 2000-12-26 Astra Aktiebolag Therapeutic preparation for inhalation
DE4425255A1 (en) 1994-07-16 1996-01-18 Asta Medica Ag Formulation for inhalation application
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
JPH10511090A (en) 1994-12-22 1998-10-27 アストラ・アクチエボラーグ Parathyroid hormone, PTH-containing therapeutic preparation for inhalation
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
BR9809499A (en) * 1997-05-27 2000-06-20 Direct Haler A S Powdered medicine inhaler
NZ509271A (en) * 1998-08-18 2003-10-31 Univ California Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
US7354894B2 (en) 1998-08-18 2008-04-08 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
ITMI991582A1 (en) 1999-07-16 2001-01-16 Chiesi Farma Spa DUST CONSTITUTED FROM PARTICLES HAVING THE PERFECTLY SMOOTH SURFACE FOR USE AS VEHICLES FOR THE PREPARATION OF INALA MIXTURES
GB9920839D0 (en) 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
EP1129705A1 (en) * 2000-02-17 2001-09-05 Rijksuniversiteit te Groningen Powder formulation for inhalation
PE20011227A1 (en) 2000-04-17 2002-01-07 Chiesi Farma Spa PHARMACEUTICAL FORMULATIONS FOR DRY POWDER INHALERS IN THE FORM OF HARD AGGLOMERATES
GB0009469D0 (en) 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
UA75375C2 (en) 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
AU757008B2 (en) * 2000-10-12 2003-01-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel tiotropium-containing inhalation powder
US20060194773A1 (en) * 2001-07-13 2006-08-31 Paratek Pharmaceuticals, Inc. Tetracyline compounds having target therapeutic activities
DE10141377A1 (en) 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Scattering process for the production of powder formulations
AU2002333644A1 (en) * 2001-09-17 2003-04-01 Glaxo Group Limited Dry powder medicament formulations
KR20040073438A (en) * 2001-11-19 2004-08-19 벡톤 디킨슨 앤드 컴퍼니 Pharmaceutical compositions in particulate form
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
US6900317B2 (en) * 2002-02-19 2005-05-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them
US20040014679A1 (en) * 2002-02-20 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co., Kg Inhalation powder containing the CGRP antagonist BIBN4096 and process for the preparation thereof
DE10207026A1 (en) * 2002-02-20 2003-08-28 Boehringer Ingelheim Kg Stable inhalable powder of the calcitonin gene-related peptide antagonist, BIBN4096, useful for treating migraine, in the form of spherical nano-structured particles obtained by spray-drying
JP2006516531A (en) * 2002-08-21 2006-07-06 ノートン　ヘルスケアー　リミテッド Inhalation composition
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10255387A1 (en) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg New tiotropium-containing powder formulation for inhalation
DE10317461A1 (en) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Preparing microparticles labeled with technetium, useful as powders for inhalation, e.g. to study deposition of pharmaceuticals, such as anticholinergic agents, involves incubation with solution of technetium salt
US20050042178A1 (en) * 2003-08-18 2005-02-24 Boehringer Ingelheim International Gmbh Microparticles containing the CGRP-antagonist 1-[N2-[3,5-dibrom-N-[[4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder
DE10338399A1 (en) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Microparticles containing the CGRP antagonist 1- [N 2 - [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1H) -oxoquinazolin-3-yl) -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyridinyl) -piperazine, process for their preparation and their use as inhalation powder
DE10338407A1 (en) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg New inhalable powders containing the CGRP antagonist 1- [N 2 - [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1H) -oxoquinazolin-3-yl) -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyridinyl) -piperazine
US20050043247A1 (en) * 2003-08-18 2005-02-24 Boehringer Ingelheim International Gmbh Spray-dried amorphous BIBN 4096, process for preparing and the use thereof as inhalative
DE10338402A1 (en) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Spray-dried, amorphous BIBN 4096, process for its preparation and its use as inhalant
US20050042179A1 (en) * 2003-08-18 2005-02-24 Boehringer Ingelheim International Gmbh Inhalative powder formulations containing the CGRP-antagonist 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine
DE10338403A1 (en) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulation containing the CGRP antagonist 1- [N 2 - [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1 H) -oxoquinazolin-3-yl] -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyrindinyl) piperazine, process for its preparation and its use as inhalant
PT1699434E (en) 2003-09-02 2011-05-03 Norton Healthcare Ltd Process for preparing a medicament
PE20050489A1 (en) 2003-11-04 2005-09-02 Glaxo Group Ltd ANTAGONISTS OF MUSCARINE ACETYLCHOLINE RECEPTORS
JP2007533387A (en) 2004-04-21 2007-11-22 イノベータ バイオメド リミテッド Inhaler
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
MY144753A (en) 2004-04-27 2011-10-31 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
US7727962B2 (en) * 2004-05-10 2010-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder comprising new compositions of oligosaccharides and methods for their preparation
US7611709B2 (en) * 2004-05-10 2009-11-03 Boehringer Ingelheim Pharma Gmbh And Co. Kg 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
US7723306B2 (en) * 2004-05-10 2010-05-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
DE102004048390A1 (en) * 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg New powder inhalants based on modified lactose mixtures as adjuvant
DE102004048389A1 (en) * 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modification of surfaces of lactose as adjuvant for use with powder inhalants
KR20070119631A (en) 2005-02-10 2007-12-20 글락소 그룹 리미티드 Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
EP2307589B1 (en) 2008-07-24 2018-12-19 L'Air Liquide Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude Method for deposition of transition metal-containing films using heteroleptic cyclopentadienyl transition metal precursors
US9925282B2 (en) 2009-01-29 2018-03-27 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
JP5809985B2 (en) 2009-02-26 2015-11-11 グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ A medicament comprising 4-{(1R) -2-[(6- {2-[(2,6-dichlorobenzyl) oxy] ethoxy} hexyl) amino] -1-hydroxyethyl} -2- (hydroxymethyl) phenol Formulation
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
PT106094A (en) 2012-01-13 2013-07-15 Hovione Farmaciencia S A ADMINISTRATION BY INHALATION OF FORMULATIONS WITH HIGH DOSE
WO2014007773A1 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Compositions comprising muscarinic receptor antagonist and sorbitol
WO2014007772A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising glucose anhydrous
WO2014007769A1 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Compositions comprising muscarinic receptor antagonist and glucose anhydrous
WO2014007771A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising muscarinic receptor antagonist
CN109846862A (en) 2012-10-25 2019-06-07 通用医疗公司 The combination treatment for treating Alzheimer disease and related disease
GB201305825D0 (en) 2013-03-28 2013-05-15 Vectura Ltd New use
US10525005B2 (en) 2013-05-23 2020-01-07 The General Hospital Corporation Cromolyn compositions and methods thereof
WO2015054280A1 (en) 2013-10-08 2015-04-16 Lam Therapeutics, Inc. Rapamycin for the treatment of lymphangioleiomyomatosis
JP2016534063A (en) * 2013-10-22 2016-11-04 ザ ジェネラル ホスピタル コーポレイション Cromolyn derivatives and related imaging and treatment methods
PL3125875T3 (en) 2014-04-04 2023-11-20 AI Therapeutics, Inc. An inhalable rapamycin formulation for treating age-related conditions
AU2015330905B2 (en) 2014-10-07 2021-02-25 AI Therapeutics, Inc. An inhalable rapamycin formulation for the treatment of pulmonary hypertension
KR20190044647A (en) 2016-08-31 2019-04-30 더 제너럴 하스피탈 코포레이션 In neuro-inflammation associated neurodegenerative diseases, macrophages / microglia
MX2019014671A (en) * 2017-06-28 2020-02-07 Philip Morris Products Sa Container with particles for use with inhaler.
KR20210070232A (en) 2017-07-20 2021-06-14 아즈테라피즈 인코포레이티드 Powdered Formulation of Cromolin Sodium and Ibuprofen
CA3105392A1 (en) 2018-07-02 2020-01-09 The General Hospital Corporation Powdered formulations of cromolyn sodium and .alpha.-lactose
US11774363B2 (en) 2018-08-07 2023-10-03 Norton (Waterford) Limited Application of raman spectroscopy for the manufacture of inhalation powders
EP4203945A1 (en) 2020-08-28 2023-07-05 Universität Linz Use of leoligin in the prevention of tissue damage

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792207U (en) 1959-04-14 1959-07-16 Esslinger Sack Und Planenfabri TRANSPORTABLE GARDEN SWIMMING POOL OR POOL WITH WALLS MADE OF PLASTIC FOIL.
FR1489749A (en) 1965-03-25 1967-07-28 Fisons Pharmaceuticals Ltd Process for the preparation of bis-chromonyl compounds and their derivatives

Also Published As

Publication number Publication date
NL6811060A (en) 1969-02-11
FI48973C (en) 1975-03-10
JPS5643448B1 (en) 1981-10-13
US3634582A (en) 1972-01-11
DE1792207C3 (en) 1978-06-29
FR8142M (en) 1970-08-17
DE1792799A1 (en) 1977-08-11
MY7400330A (en) 1974-12-31
IE32343B1 (en) 1973-06-27
FR1605538A (en) 1979-02-23
NL161984B (en) 1979-11-15
CA946280A (en) 1974-04-30
GB1242211A (en) 1971-08-11
NO128307B (en) 1973-10-29
DE1792207A1 (en) 1971-11-04
MY7400329A (en) 1974-12-31
NL161984C (en) 1980-04-15
FI48973B (en) 1974-12-02
DE1792207B2 (en) 1977-10-13
BE718846A (en) 1969-01-31
IE32343L (en) 1969-02-08
SE372420B (en) 1974-12-23

Similar Documents

Publication Publication Date Title
DK123276B (en) Process for the preparation of an easily fluidizable inhalant.
DK137232B (en) Analogous process for the preparation of phenylethanolamines.
DK122222B (en) Process for the preparation of alk-3-en-1-ols.
DK133783B (en) Process for the preparation of 7-halo-7-deoxy-1-thio-alpha-D-galacto-octopyranosides.
DK120698B (en) Analogous process for the preparation of acetylguanidines.
DK124080B (en) Process for the preparation of D-6-methyl-8-cyanomethylergoline.
DK128605B (en) Process for the preparation of percarboxylic acids.
DK119307B (en) Process for the preparation of ketonitriles.
DK124536B (en) Analogous process for the preparation of 4-aryl-3-hydroxybutyrohydroxamic acid.
DK124690B (en) Analogous process for the preparation of 2-chlorovinylmethyl-alkyl phosphates.
DK136033B (en) Process for the preparation of indolyl-3-acetic acids.
DK122758B (en) Process for the preparation of α-methyl-multicyclo-methylamines.
DK123100B (en) Process for the preparation of N-tritylimidazoles.
DK122522B (en) Process for the preparation of dichloroquinolines.
DK119663B (en) Analogous process for the preparation of 2-benzenesulfonamidopyrimidine compounds.
DK127252B (en) Process for the preparation of oxirane compounds.
DK119976B (en) Analogous process for the preparation of 18-methyl-19-nor-17α-hydroxyprogesterones and -17-esters thereof.
DK130705B (en) Process for the preparation of separate phosphatides.
DK129197B (en) Process for the preparation of 10-hydrocarbon-substituted 5-hydroxy-13β-alkyl-Δ <9 (11)> gones.
DK123291B (en) Process for the preparation of methyl isobutyl ketone.
DK123476B (en) Process for the preparation of 3-oxo-A-nor-B-homo-estra-5 (10) -enes.
DK117568B (en) Analogous process for the preparation of phthalazino-phthalazine dions.
DK122666B (en) Analogous process for the preparation of hydrocortisone-17-cyclopentanecarboxylate.
DK116996B (en) Process for the preparation of 14β-hydroxy-3-oxo-5β-card-20 (22) -enolides.
DK117900B (en) Analogous process for the preparation of 1-aminoacyl-quinazolin-4-ones.